# US 2024/0166607 A1 · Processes for making modulators of cystic fibrosis transmembrane conductance regulator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0166607 A1
- Document ID: US20240166607A1
- Status: Published application
- Kind: A1
- Application number: 18/211,772
- Filed: 2023-06-20
- Published: 2024-05-23
- Earliest claimed: 2017-12-01
- Assignees: Vertex Pharmaceuticals Incorporated
- Applicants: Vertex Pharmaceuticals Incorporated
- Inventors: Berenice Lemercier Lewandowski; Robert Lewis; Adam Looker; Adam Morgan; Stefanie Roeper; Michael Ryan; Juan Gabriel Solsona Rocabert; Nathan Wilde
- Web page: https://patentgrep.com/patent/US20240166607A1

## CPC

- C07D 215/56: with oxygen atoms in position 4
- C07B 59/002: {Heterocyclic compounds}
- C07C 37/0555: {being esterified hydroxy groups}
- C07C 37/16: by condensation involving hydroxy groups of phenols or alcohols or the ether or mineral ester group derived therefrom
- C07C 39/06: Alkylated phenols
- C07C 39/27: all halogen atoms being bound to ring carbon atoms
- C07C 68/02: from phosgene or haloformates
- C07C 68/06: from organic carbonates
- C07C 69/96: Esters of carbonic or haloformic acids
- C07C 201/08: by substitution of hydrogen atoms by nitro groups
- C07C 205/43: to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C 219/34: having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The disclosure provides processes for synthesizing compounds for use as CFTR modulators.

## Claims

### Claim at position 1

-5. (canceled)

### Claim 6

A process for the preparation of compound 2:
comprising:
a) converting compound 21:
into compound 20:
wherein the conversion of compound 21 into compound 20 is performed in the presence of KNO3 and/or NaNO3, AlCl3, and optionally one or more of trimethylsilyl chloride and TiCl4;
b) converting compound 20 into compound 7:
c) reacting compound 3:
with compound 7 to produce compound 8:
and
(d) converting compound 8 into compound 2;
wherein the methyl (Me) of the —OCO2Me of compound 7, 8, 20, and 21 is optionally replaced by a group selected from aliphatic, heteroaliphatic, heterocyclic, haloaliphatic, aryl, and heteroaryl.

### Claim at position 3

-33. (canceled)

### Claim 34 (depends on 6)

The process of claim 6, wherein the conversion of compound 21 into compound 20 is performed in the presence of KNO3 and AlCl3.

### Claim 35 (depends on 6)

The process of claim 6, wherein the conversion of compound 21 into compound 20 is performed in the presence of KNO3, AlCl3, and trimethylsilyl chloride.

### Claim 36 (depends on 6)

The process of claim 6, wherein the conversion of compound 21 into compound 20 is performed in the presence of NaNO3 and AlCl3.

### Claim 37 (depends on 6)

The process of claim 6, wherein the conversion of compound 21 into compound 20 is performed in the presence of a solvent.

### Claim 38 (depends on 37)

The process of claim 37, wherein the solvent is CH2Cl2.

### Claim 39 (depends on 6)

The process of claim 6, wherein compound 21 is produced by converting compound 22:
into compound 21.

### Claim 40 (depends on 39)

The process of claim 39, wherein compound 22 is produced by converting compound 23:
into compound 22 in the presence of CD3MgI.

### Claim 41 (depends on 40)

The process of claim 40, wherein compound 23 is produced by converting compound 24:
into compound 23.

### Claim 42 (depends on 41)

The process of claim 41, further wherein compound 24 is produced by converting compound 25:
into compound 24.

### Claim 43 (depends on 42)

The process of claim 42, wherein compound 25 is produced by converting compound 26:
into compound 25.

### Claim 44

A process for the preparation of compound 2:
comprising:
a) converting compound 16:
into compound 15:
wherein the conversion of compound 16 into compound 15 is performed in the presence of KNO3 and/or NaNO3, AlCl3, and optionally one or more of trimethylsilyl chloride and TiCl4;
b) converting compound 15 into compound 7:
c) reacting compound 3:
with compound 7 to produce compound 8:
and
(d) converting compound 8 into compound 2;
wherein the methyl (Me) of the —OCO2Me of compounds 7, 8, 15, and 16 is optionally replaced by a group selected from aliphatic, heteroaliphatic, heterocyclic, haloaliphatic, aryl, and heteroaryl.

### Claim 45 (depends on 44)

The process of claim 44, wherein the conversion of compound 16 into compound 15 is performed in the presence of KNO3 and AlCl3.

### Claim 46 (depends on 44)

The process of claim 44, wherein the conversion of compound 16 into compound 15 is performed in the presence of KNO3, AlCl3, and trimethylsilyl chloride.

### Claim 47 (depends on 44)

The process of claim 44, wherein the conversion of compound 16 into compound 15 is performed in the presence of NaNO3 and AlCl3.

### Claim 48 (depends on 44)

The process of claim 44, wherein the conversion of compound 16 into compound 15 is performed in the presence of a solvent.

### Claim 49 (depends on 48)

The process of claim 48, wherein the solvent is CH2Cl2.

### Claim 50 (depends on 44)

The process of claim 44, wherein compound 16 is produced by converting compound 17:
into compound 16.

### Claim 51 (depends on 50)

The process of claim 50, wherein compound 17 is produced by converting compound 18:
into compound 17.

### Claim 52 (depends on 51)

The process of claim 51, wherein compound 18 is produced by converting compound 19:
into compound 18.

### Claim 53 (depends on 52)

The process of claim 52, wherein compound 19 is produced by converting tert-butyl phenol (compound 14):
into compound 19.
